Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse. - Wikidata - awgldk - TriplyDB

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

http://www.wikidata.org/entity/Q34463834

about

A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.Investigations of clofibrate in alternative carcinogenicity models.Evaluation of the carcinogenic potential of clofibrate in the p53+/- mouse.Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after oral administration--part I.Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.

P2860

Q30488346-C55D5851-9DA3-4916-BB8C-E87ED67CA701 Q38158164-FE5A6DEB-765D-47BF-BB04-E932A68BC270 Q46249387-D63E0D79-8D8D-4D7F-86BB-AAED7C73534B Q46781510-DA0AFD57-B774-4353-8BDB-834A2AD8903F Q46781515-7E940901-CF5B-4BE4-BA2D-0EEC76F899ED Q46781520-F2FC989C-9AE3-46EE-B3B0-005109678B25 Q46781523-06E2ED27-7666-4582-8E28-D405A6D06736 Q46781526-06C693EE-8F83-44B5-B529-0A7FE23E8C42

P2860

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

http://www.wikidata.org/entity/Q34463834

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@ast

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@nl

type

label

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@ast

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@nl

prefLabel

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@ast

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@en

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@nl

P1433

Q34463834-C22822CF-E6D8-491A-A57A-74B9DB663CE7

P1476

Q34463834-E7EBB1ED-1F94-4D5D-A094-F09909D93974

P2093

Q34463834-4516643A-E0E9-42BC-A68D-43B8E1F792A8

Q34463834-5B8D2E2E-97CF-4C25-9CA3-52CFE87BA040

Q34463834-84DD3240-EA47-4E95-B016-2C0D59B48D32

Q34463834-A011A0B9-8D61-4251-925E-59255612C472

Q34463834-BE1249D3-3657-4FF0-88D3-FB75C1626214

Q34463834-C8BA2EF8-883B-486C-9FA8-2813F68B14D6

Q34463834-D452C4FA-D0C6-42B1-B443-3A07C04408EA

Q34463834-D455F4F3-1F9D-41A7-83EE-CF70F5E00F6D

P2860

Q34463834-084C1179-5257-48B4-B343-7D041F842B5E

Q34463834-0AC479A2-FA54-4EC1-BB05-3277A0316A30

Q34463834-0CAEC807-E20D-4B1B-B20C-D8944D592AFE

Q34463834-1A7A0333-077D-43C0-B7D3-2890197DCDAD

Q34463834-2225B5C9-B4F9-4763-BBD1-9271554BF026

Q34463834-308276FC-3CCB-45A8-9A41-9BE9D7089B9F

Q34463834-35FD8BC3-4D15-4D99-8690-D82A85532BF9

Q34463834-43A44B18-74DB-4251-9E8A-C82DF6199396

Q34463834-44162B74-B6DD-4F8A-9539-B6FA9A1A97BB

Q34463834-45CBE566-F447-4CDA-8230-AE7BF325493B

P304

Q34463834-9968DA4E-DDAC-437D-9AB5-8621DAE61092

P31

Q34463834-4854F5FD-AD32-408B-90CD-02A3D9921D97

P356

Q34463834-E14B365F-2045-4511-815C-6F7BDCFAD509

P433

Q34463834-B4ADAEA9-2812-4AB3-A94F-1B500CED24F3

P478

Q34463834-8D25A49E-8F05-4693-9A8D-3142BDD2658C

P577

Q34463834-780DBD53-16EB-4649-A1E1-2C409F1397B6

P698

Q34463834-0AEF0521-5639-4575-99FE-9265A0097F6A

P356

10915810500210401

P1433

International Journal of Toxicology

P1476

Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse.

@en

P2093

Debie J Hoivik

http://www.w3.org/2001/XMLSchema#string

Douglas Rickert

http://www.w3.org/2001/XMLSchema#string

Jane S Allen

http://www.w3.org/2001/XMLSchema#string

Krzysztof Selinger

http://www.w3.org/2001/XMLSchema#string

Michael J Santostefano

http://www.w3.org/2001/XMLSchema#string

Richard T Miller

http://www.w3.org/2001/XMLSchema#string

Sarah R Nesfield

http://www.w3.org/2001/XMLSchema#string

Thomas C Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

P53+/- hemizygous knockout mouse: overview of available data.

Thiazolidinediones.

Neonatal mouse model: review of methods and results.

Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute.

Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.

PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

Lipotoxic heart disease in obese rats: implications for human obesity.

P304

341-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10915810500210401

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16257853

http://www.w3.org/2001/XMLSchema#string